| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.30B | 19.22B | 21.89B | 24.09B | 24.81B | 23.90B |
| Gross Profit | 2.89B | 3.04B | 2.68B | 4.00B | 3.57B | 3.89B |
| EBITDA | -445.25M | 1.37B | -954.00M | 1.86B | 1.46B | 1.88B |
| Net Income | -1.83B | 236.00M | -2.26B | 221.00M | -104.00M | 370.00M |
Balance Sheet | ||||||
| Total Assets | 28.84B | 29.98B | 29.81B | 33.20B | 34.17B | 33.97B |
| Cash, Cash Equivalents and Short-Term Investments | 3.44B | 5.18B | 4.44B | 4.40B | 4.59B | 6.66B |
| Total Debt | 9.11B | 11.77B | 11.80B | 11.80B | 11.84B | 11.91B |
| Total Liabilities | 18.63B | 19.34B | 19.43B | 21.39B | 22.80B | 23.26B |
| Stockholders Equity | 10.21B | 10.63B | 10.38B | 11.81B | 11.36B | 10.71B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 902.00M | 73.00M | -272.00M | -2.03B | 1.66B |
| Operating Cash Flow | 0.00 | 1.41B | 1.51B | 399.00M | -1.31B | 2.25B |
| Investing Cash Flow | 0.00 | -531.00M | -1.34B | -736.00M | -845.00M | -518.00M |
| Financing Cash Flow | 0.00 | -186.00M | -168.00M | -223.00M | -254.00M | -337.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥99.14B | 136.93 | 5.02% | 3.23% | -30.60% | -84.58% | |
73 Outperform | ¥56.25B | 13.82 | ― | 2.54% | 3.47% | -12.26% | |
69 Neutral | ¥15.29B | 4.56 | ― | 3.41% | 1.98% | 150.85% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥30.41B | 20.20 | ― | 3.56% | -2.79% | -35.37% | |
60 Neutral | ¥3.63B | 14.42 | ― | 1.93% | -12.19% | ― | |
49 Neutral | ¥4.27B | 12.01 | ― | 4.06% | 3.22% | 215.32% |